News Hub | News Direct

Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
Article thumbnail News Release

Borroe Finance’s Ambitious Roadmap: Paving the Way for the Future of Cryptocurrency!

Blockchain Digest

Borroe Finance ($ROE) is the final push the Web3 industry needs to be able to unlock its fullest potential. The platform propels the rapid development of the Web3 sector by providing timely and efficient access to needed working capital to ensure the smooth delivery of goods and services. The development team at Borroe understands the areas where traditional revenue financing falls short, and it bridges those gaps using blockchain technology and AI services. Analysts agree that $ROE’s expected 300% increase makes it one of the best crypto investments. Let’s see why $ROE is the token to buy today! >>BUY $ROE TOKENS NOW<< What Is Borroe's ($ROE) Mission? Borroe ($ROE) is a blockchain project launched after carefully analyzing the Web 3.0 business landscape and its unique bottlenecks. Borroe ($ROE) recognizes a need for quick access to secure loans that serve as working capital to ensure the smooth running of business operations. Furthermore, it recognizes the particular limitations of the traditional finance industry when it comes to revenue financing. Through a Polygon-powered decentralized marketplace, Borroe ($ROE) democratizes free access to easy fundraising services. It allows users to customize their fundraising requests to reflect the particular needs of their businesses. Borroe’s ($ROE) unique service offering makes it one of the best crypto to buy now. How Does Borroe ($ROE) Make Fundraising Easy? Traditional finance platforms would have users go through lengthy verification processes that cost extra time and money, which can be very impactful on the growth of businesses. With Borroe ($ROE), getting access to fundraising is as easy as the following steps. 1) Register with Borroe ($ROE). Get a credit rating generated after completing an onboarding process that involves AI risk assessment. Your credit rating would also show the size of your eligible loans. 2) Receive a minted NFT showing your future income and the loan agreement, which will be enforced by fully decentralized smart contracts. 3) Sell the minted NFT on Borroe's ($ROE) fundraising marketplace. Interested buyers will automatically be notified of your sale by Borroe ($ROE). 4) Your loan is automatically repaid at the agreed time. NB: To attract buyers, users can sell NFTs at attractive discounts or include other benefits like special rewards. Borroe ($ROE) Is Changing the Narrative Around Revenue Financing: Roenomics Explained Borroe ($ROE) was built on Polygon and enjoys the network's speedy transactions, security, and excellent scaling capabilities. $ROE has a built-in 3% buy/sell tax. Its total supply is capped at 1 billion $ROE tokens. Token holders enjoy: Special discounts on the marketplace and other transaction fees. Priority alerts on the newest sales and notifications from repeat funding applications. Voting rights and rewards limited to certain topics. Special recognition for user participation in Borroe's ($ROE) marketplace. Special access to on and off-ramp crypto and fiat payment solutions, which eases the process of doing business for Web 3 companies. Borroe's ($ROE) smart contract address is public, as well as its recently completed security audit by BlockAudit. Borroe's popularity is rising steadily, especially after its recent 25% increase. After finding out that $ROE is expected to rise by 300% at the end of its presale, many investors now believe it is one of the top crypto ICOs of 2023. Learn more about Borroe ($ROE) here: Visit Borroe Presale | Join The Telegram Group | Follow Borroe on Twitter Contact Details Borroe Finance Borroe Finance PR Team press@borroe.finance

August 31, 2023 03:49 AM Eastern Daylight Time

Article thumbnail News Release

Forecasting the Tokens To Lead the Next Bull Wave: Shiba Inu, THORChain, Pomerdoge

Total Media

In the never-ending quest for cryptocurrencies with upside potential, Shiba Inu (SHIB), THORChain (RUNE), and Pomerdoge (POMD) stand out. Their enormous growth potential, coupled with vibrant ecosystems and unique offerings, makes them our top picks. In this article, we will take a look at the factors that will contribute to their ascent as the next bull wave nears. Click Here To Find Out More About The Pomerdoge (POMD) Presale Shiba Inu (SHIB): A Potential Leader of the Next Bull Wave Shiba Inu (SHIB), after capturing the imagination of the crypto world with its meme appeal, has grown to become a top token in the crypto landscape. Not only that, Shiba Inu also has one of the most dedicated crypto communities, which plays a crucial role in its growth. These factors contributed to Shiba Inu’s journey from obscurity to prominence, which has been fascinating.In light of the recent developments within the Shiba Inu ecosystem, it is a strong contender to lead the next bull wave. The launch of Shibarium and other ongoing initiatives make SHIB a token to hold in anticipation of the bull run. So, don’t miss out on the potential growth that comes with holding some Shiba Inu. THORChain (RUNE): Revolutionizing DeFi THORChain (RUNE) is a decentralized liquidity protocol. It allows seamless cross-chain exchange of assets without losing full custody, making THORChain a key player within the decentralized finance (DeFi) sector. Considering THORChain’s vision to revolutionize DeFi, it is a token that shouldn’t be overlooked. The growing adoption of interoperability and the increasing demand for this solution make THORChain one to hold before the next bull cycle. The reason is that it will experience explosive growth as it harnesses the momentum of the bullish wave. Lastly, THORChain’s critical role in DEX and DeFi makes it a popular option among investors. Pomerdoge (POMD): The Intersection Between Meme and Utility Amidst the established players, Pomerdoge (POMD) emerges as a newcomer with ambitious aspirations. Its whimsical nature, blended with NFT and P2E features, makes it poised for massive growth. Moreover, as a presale token, its growth potential is unrivaled, thereby leading to a surge in its demand. Pomerdoge’s narrative taps into the excitement of potential gains, which market analysts and top experts predict will surpass 3,000% in 2023. Its significant growth potential makes it set to lead the impending bullish wave, thus sparking substantial interest in its presale. At the time of writing, more than $1 million has been raised, proof of confidence in its road map, unique offering, and growth potential.Its vibrant ecosystem will feature a P2E game that will connect and network players across countries. In addition to networking, players will play a competitive game and earn rewards, thereby increasing activity. Additionally, the ecosystem will host an NFT collection, which will attract even more users to the platform. The POMD token presale recently kicked off, with a token at $0.008. Find out more about the Pomerdoge (POMD) Presale Today: Website: https://pomerdoge.com/ Telegram Community: https://t.me/pomerdoge Contact Details Pomerdoge Pomerdoge PR & Media pr@pomerdoge.com

August 31, 2023 03:42 AM Eastern Daylight Time

Article thumbnail News Release

Retail Commercial Real Estate Leasing Sets 8-Year Record, See How This Company Is Cashing In On Neighborhood Centers

Benzinga

By Faith Ashmore, Benzinga The commercial real estate industry is grappling with rising inflation and interest rates, as well as other socioeconomic changes that are shaping its trajectory. These challenges have emerged due to a combination of internal and external factors, impacting various segments within the industry. One significant macro problem is the evolving work environment, influenced by the global pandemic and the shift towards remote work. With more employees working from home or adopting hybrid work models, there is a growing concern about the future demand for office space. The industry is grappling with the transformation of retail spaces into experiential and mixed-use developments to remain relevant in the face of e-commerce competition. However, there will always be a need for certain commercial real estate – especially necessity-based real estate. Necessity-based real estate refers to properties that are essential for everyday living and are often in demand regardless of market conditions. This includes sectors such as healthcare facilities, grocery stores, multifamily housing and more. Investing in necessity-based real estate can be a great tool for investors to build resilience and safeguard their investments against market swings. Necessity-based properties have historically shown consistent demand even during economic downturns, making this type of investment suitable for even the current market. The inherent stability of demand in necessity-based real estate contributes to the reduction of risks associated with market fluctuations. By incorporating these essential and reliable property types into their investment strategy, investors can effectively diversify their portfolios. This strategic approach allows investors to mitigate risk, protect their capital and establish long-term financial resilience. Some necessity-based properties are seeing extreme success in today’s market due to unique socio-economic conditions. According to a July 27 article for paid subscribers in The Wall Street Journal titled "The Hottest Real-Estate Play Is in Your Neighborhood," there is a significant opportunity in the commercial real estate sector – particularly in strip malls. Leased occupancy reached an 8-year high of 95.3% in the first quarter of this year, while physical occupancy remained close to its pre-pandemic level at 92.4%. This is because landlords are signing leases faster than retailers are able to move in. Flexible working is contributing to this growth because consumers are spending more time at home and less time in city centers where their offices are located. Additionally, the migration of approximately 2 million people from large cities to suburbs and exurbs has further boosted the demand for strip centers. With office occupancy still at only half of pre-pandemic levels, workday lunches have moved from downtown city centers to restaurants in strip malls closer to people's homes. Additionally, personal care services such as massage, chiropractic, medical laboratory and dental services, which are commonly found in strip retail centers, have experienced strong demand in recent years. First National Realty Partners (FNRP), a renowned necessity-based real estate firm, has established itself as the leader and says it is the inventor of the specific industry. With an impressive track record of success, FNRP has established itself as the go-to investment firm for accredited investors seeking to diversify and navigate the necessity-based market. With over $2 billion in assets under management, FNRP has demonstrated its ability to deliver results for investors. The company’s portfolio boasts an impressive 57 current assets held, showcasing its expertise in identifying and acquiring high-quality properties that align with its investment strategy. Since its inception, FNRP has distributed over $100 million to its valued investors, a testament to generating returns. Its successful growth is evidenced by the acquisition of over 11.5 million square feet of gross leasable area (GLA) across 23 states, solidifying a national presence and extending reach to diverse markets. One key component of FNRP’s strategy is to take advantage of looming headwinds in the real estate market, and it aims to acquire numerous properties at significant discounts over the next few quarters. The company believes that it will be able to leverage its cash and stable positioning to step in and significantly increase its holdings even as competitors sell. As many industry players are looking at selling and drawing down their portfolios, it’s important to understand which firms are prepared. With its focus on recession-resilient real estate, FNRP continues to explore innovative solutions to navigate the current landscape and lay the foundation for future success – accredited investors may want to take note. Learn more about FNRP’s upcoming deals here. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 30, 2023 09:15 AM Eastern Daylight Time

Article thumbnail News Release

Second Most Fatal Cancer In U.S. May Face A Big Fight From Mainz Biomed’s Non-Invasive Test; (NASDAQ: MYNZ) Is Making Early Detection Possible

Benzinga

By Faith Ashmore, Benzinga Colorectal cancer is the third most common cancer worldwid e, and the second most fatal. Although the majority of colorectal cancer cases have historically occurred in individuals aged 50 and older, it is increasingly affecting younger people. Alarming statistics reveal that new cases of colorectal cancer in individuals under the age of 50 have been steadily rising over the past few decades. Colorectal cancer is now the leading cause of cancer death for Americans between the ages of 20 and 59 years old according to the National Cancer Institute. However, younger adults are not routinely screened for colorectal cancer as it is still relatively uncommon in their age group. Determining the exact reasons for this uptick remains a challenge, although many experts believe this trend is being driven by a sedentary lifestyle, obesity, smoking, heavy alcohol use, low-fiber, high-fat diets or diets high in processed meats and other environmental factors. However, even without absolutely clear answers, regular screening is crucial to early detection followed by highly successful treatment of colorectal cancer. The CDC reports that colorectal cancer is the second most fatal cancer in the United States and Europe. However, it is also the most preventable, with early detection leading to survival rates above 90%. Given the rising incidence in young individuals and the majority's lack of regular screenings until later in life, accessible screenings are more important than ever. By providing efficient and convenient methods for early detection, healthcare professionals can make significant progress in combating colorectal cancer and ultimately save countless lives. Mainz Biomed (NASDAQ: MYNZ), a company that specializes in developing molecular genetic diagnostic solutions for life-threatening conditions, has created ColoAlert, an innovative product that addresses the need for easier and more accessible cancer screenings for quick detection and treatment of colorectal cancer. This non-invasive and user-friendly test aims to make colorectal cancer screening fast, simple and precise. The test is the first DNA-based screening test for colorectal cancer in Europe. ColoAlert has been recommended by the U.S. Preventive Services Task Force – stool DNA tests, such as ColoAlert, should be conducted once every three years, starting at age 45. Every year, 16.6 million colonoscopies are performed in the U.S. alone, and yet one-third of U.S. residents aged 50-75 have never been screened for colon cancer. Many times, fear of a colonoscopy contributes to populations avoiding the screening; ColoAlert is a non-invasive solution to the long-standing apprehension. Simply put, this innovative screening tool is not limited to younger ages. In fact, ColoAlert may have an annual market opportunity in excess of $4.0 Billion in the U.S. for testing populations aged 50 and above every three years. ColoAlert's unique genetic profiles allow for tailored treatment for each individual patient, leading to better health outcomes for patients with colorectal cancer. This revolutionary product is a major stride in combating colorectal cancer and has the potential to save countless lives. Mainz Biomed is quickly emerging as a strong contender in the diagnostic industry, putting renowned companies like Exact Sciences (NASDAQ: EXAS) and Geneoscopy Inc. on notice. While both Exact Sciences and Geneoscopy utilize DNA and RNA biomarkers respectively, Mainz Biomed is breaking new ground by revolutionizing the field with its cutting-edge evaluation of groundbreaking patent-pending mRNA biomarkers. This is evident by the company's ColoAlert® recent success in the market. The revenues generated by ColoAlert® in the first half of 2023 surged by an impressive 108% when compared to the same period in 2022. This remarkable growth further solidifies Mainz Biomed's position in the industry and showcases its ability to develop groundbreaking products that meet the needs of healthcare professionals and patients alike. With its pioneering approach and revenue growth over H1 this year, Mainz Biomed seems poised to disrupt the market and establish itself as a trusted and innovative provider of molecular genetic diagnostic solutions. Their commitment to pushing the boundaries of diagnostic technology and growth trajectory seems to be making them a force to be reckoned with in the industry, setting them apart from their competitors. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

August 30, 2023 09:15 AM Eastern Daylight Time

Article thumbnail News Release

Logitix Names Sports Industry Executive Travis Apple as Chief Revenue Officer

Logitix

Logitix, the leader in live event ticketing technology and analytics, announced it has named Travis Apple as Chief Revenue Officer. Apple will oversee all revenue for Logitix as the organization continues to bring innovation to the ticketing landscape in sports and entertainment. Apple’s extensive sports industry experience includes overseeing ticket sales and service for organizations in the NBA and MLB. Apple joins an experienced team at Logitix that works with over 400 teams and properties from the MLB, NFL, NBA, NHL, NCAA, and other live event companies across the sports, music, performing arts, and entertainment industries. As CRO, Apple will connect the ticket-selling world to Logitix’s unique platform that analyzes millions of real-time data points and provides up-to-the-minute insights within the live event marketplace. “Travis brings incredible experience and expertise across our diverse market segments,” said Logitix CEO Stu Halberg. “Having been a Logitix partner, a competitor, and a decision maker to many of Logitix’s clients, Travis understands the needs of our industry and the value that Logitix brings to any ticketing strategy.” Apple is an award-winning author, weekly podcast host, and business strategist and was most recently the Executive Vice President for General Sports Worldwide, an executive search and training firm. Prior to that, he was Vice President of Ticket Sales & Service for the Miami Marlins (MLB) and Senior Director of Team Marketing and Business Operations (TMBO), where he oversaw ticketing for all of the NBA, WNBA, and G-League teams. “I am thrilled to be joining the impressive Logitix team and showcasing the innovative technology that we can provide to sports and entertainment clients,” says Apple. “Throughout my team and league experience, it became clear there is an opportunity for the right partnerships to drive business operations. This new role combines my passion for identifying difference-making technology to help drive sports and entertainment business operations. I look forward to providing those services for our global clients. ” Earlier in his career, Apple was the Vice President of Ticket Sales & Service for the Phoenix Suns (NBA), Phoenix Mercury (WNBA), Arizona Rattlers (AFL), and Northern Arizona Suns (G-League). Before his time in Arizona, he was the Senior Director of Ticket Sales for the Orlando Magic (NBA) and the Director of Business Development for the Pittsburgh Pirates (MLB). He started his career with the Atlanta Hawks (NBA), Atlanta Thrashers (NHL), and State Farm Arena. Apple has established himself as a thought leader in the sports industry, having written the book Hustle Your Way to $ucce$$ in Sports Sales. He also hosts a weekly podcast, 52 Weeks of Hustle, where he sits down with industry leaders to discuss their career paths and what it takes to be successful. He graduated from Ashland University with a triple major in Sports Communication, Electronic Media Production, and Journalism. About Logitix Logitix is the preeminent monetization engine and ticketing platform for the live event industry, combining optimized pricing, distribution, and inventory management with real-time insights to help sellers and buyers respond to a rapidly changing market environment. The Logitix vision is to automate the entire ticket life cycle and provide data-driven insights to serve the diverse needs of its clients. The company is backed by ZMC and is privately held. For more information about Logitix, visit Logitix.com or find them on LinkedIn. Contact Details Eric Nemeth +1 602-502-2793 nemeth@ericpr.com Company Website https://logitix.com/

August 30, 2023 08:15 AM Eastern Daylight Time

Article thumbnail News Release

AI for good: Voxel AI tech is saving industrial workers’ lives as it increases funding to $30m with strategic funding round

Voxel

Every year over 340m workers suffer a workplace injury: slips and falls, strains and sprains, vehicle collisions and crashes. Voxel, an AI startup using computer vision to transform safety and operations in the workplace, is today announcing a $12m strategic funding round to improve workplace safety and save lives. The strategic funding round was led by global manufacturing industry leader Rite-Hite with participation from existing investors Eclipse Ventures and World Innovation Lab. This takes total funds raised to $30m since 2020. In the US, manufacturing, logistics, and physical operations are the lifeblood of the economy, with over 25 million individuals at the frontlines, contributing to 40% of the nation’s GDP. However, with massive output comes the persistent challenge of workplace injuries and operational inefficiencies. Now, artificial intelligence is revolutionizing the field of environment, health and safety (EHS) in industrial operations. Voxel integrates state-of-the-art computer vision technology into existing security cameras to identify hazards, risky behaviors, and operational inefficiencies across a diverse range of workplaces. Once potential risks, such as near-miss vehicle collisions, blocked exits, improper ergonomics,or spills, are identified, a real-time alert is sent to on-site personnel who can take immediate action, and Voxel's analytics help sites identify operational inefficiencies and design policies to prevent future issues. These proactive measures allow businesses to significantly reduce worker’s compensation and general liability costs, while improving their operations. In order to protect workers’ privacy, Voxel’s AI ethics policy means that no facial recognition or identification of individuals is permitted in their systems. Voxel provides its customers with resources for ethically and responsibly implementing AI in the workplace crafted after years of experience developing AI for America’s industrial leaders. Voxel has had a transformative impact for their strategic partners’ operations, reporting up to an 80% reduction in workplace injuries and substantially improving operational efficiency. Fortune 500 firms like Michael’s, Dollar Tree, Clorox, PPG Industries, Office Depot, and many others are already seeing the benefits of Voxel’s platform. Alex Senemar, CEO and co-founder of Voxel commented: “AI is saving lives. We’ve proven that our technology has made great strides toward reducing injuries and saving lives. Our approach is going to create worksites where employers don't have to bargain between meeting safety standards and meeting their productivity goals. The future of work is not just about doing more, but doing it safer in an environment fit for purpose”. Voxel business highlights (since series A funding round, April 2022) The team has grown from 10 people to over 50 employees, who have joined from established industry firms Samsara and Verkada to big tech Google, Apple, and Uber Featured in the Fast Company magazine Most Innovative Companies list Best B2B Tech Tool of 2023 by Products That Count. Voxel’s team is led by CEO Alex Senemar, who previously co-founded Sherbit, an AI-powered remote health monitoring system for hospitals (acquired in 2018) as well as co-founders, CTO Anurag Kanungo, who co-founded Sherbit with Senemar, and led the Machine Learning Systems Team at Uber’s Self Driving Unit; Harishma Dayanidhi, who developed self-driving car technology at Uber and Aurora; and Troy Carlson, former software engineer at Google. About Voxel Voxel uses artificial intelligence to enable security cameras to automatically identify potential workplace hazards, high-risk activities, and operational inefficiencies, allowing on-site personnel to address concerns in real-time. The platform keeps workers safe, while helping companies significantly reduce overhead costs from general liability, worker's compensation, and property claims. ​​Voxel software is transforming operations in warehousing, manufacturing, retail, transportation, construction, and oil & gas. A demo is available upon request. For more information, visit https://www.voxelai.com/ About Rite-Hite Rite-Hite is a world leader in the manufacture, sale, and service of loading dock equipment, industrial doors, safety barriers, HVLS fans, industrial curtain walls, and more - all designed to improve safety, security, productivity, energy savings, and environmental control. Watch Rite-Hite's Always Looking Ahead video to learn more. About Eclipse Ventures With over $2 billion in assets under management, 70 portfolio companies, and a team of investors with deep expertise in technology, manufacturing, supply chain, logistics, healthcare, and consumer products, Eclipse is one of the US’ leading venture capital organizations. Its leadership team has the experience necessary to create and scale complex operations – with partners coming from industry giants, such as Flextronics, Tesla, Apple, Samsara, Intel, and GE. Eclipse partners with entrepreneurs boldly transforming the essential industries that define and propel economies. For more information, visit www.eclipse.vc. Contact Details Voxel Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.voxelai.com/

August 30, 2023 07:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

FTN Network Announces Multi-Year Contract with Football Data Giant Aaron Schatz

FTN Network

FTN Network, a company built for delivering affordable, customizable, and highly detailed and advanced NFL data for betting, season-long fantasy, and daily fantasy, announced today that it has signed industry-leading football data analyst and DVOA creator Aaron Schatz to a multi-year contract and named him Chief Analytics Officer. On the heels of his decision to partner with FTN for the release of his industry-leading Football Almanac, Schatz joins FTN after leaving Football Outsiders, which he created in 2003. FTN Network will now feature Schatz’s DVOA, a unique statistical method of evaluating football teams, units or players, and all of Schatz’s football-related content. Football lovers will be able to find Schatz’s insights on FTN Bets, FTN Daily and FTN Fantasy. FTN Bets subscribers will see DVOA (Defense-Adjusted Value Over Average) and other impactful stats such as adjusted line yards incorporated into its NFL Model, while FTN Daily customers will have access to DVOA vs specific defenders. Its daily fantasy player projections and rankings will also incorporate Schatz’s extensive data. FTN Fantasy will have DVOA, Defense-adjusted Yards Above Replacement (DYAR) and many other stats unique to Schatz’s analytics available to its subscribers. Lastly, DVOA will also be integrated into FTN Data’s business-to-business offering for 2024. This will be the first time Schatz’s unique NFL Data is available directly to other businesses. “Adding Aaron as Chief Analytics Officer for the long term and as a voice in the FTN community was of utmost importance to us,” said FTN Network CEO Kevin Adams. “The day we launched the 2023 FTN Football Almanac, the site almost crashed and we had to upgrade our server capacity fourfold, showcasing the literal impact Aaron’s talents have made on our site already. Aaron is the best of the best, and we’re incredibly proud to be able to offer Aaron and his data and insights to our community, and continue to provide the best leg up when it comes to fantasy and betting.” In addition to his written work, Aaron will also co-host a bi-weekly podcast with NFL writer Mike Tanier on the FTN Podcast Network entitled “The Schatz & Tanier NFL Podcast.” Schatz will also run a premium Discord channel where he will field questions directly from FTN subscribers. “I have been incredibly impressed with FTN since our first meeting for the 2023 Football Almanac,” Schatz said. “The resources and support that I have received since I started working with FTN have not only been a natural fit, but have made the adjustment to my new environment almost seamless. Because of the flexibility and depth of FTN’s data, I’ve been able to prepare for the upcoming football season without skipping a beat. I’m looking forward to creating more engaging content for the FTN community over the next few years.” Schatz’s resume also includes writing for ESPN.com and ESPN The Magazine, and appearances as a regular panelist on ESPN 2’s Numbers Never Lie, among other accomplishments. He has spoken at numerous conferences including the MIT Sloan Conference and he has written for many esteemed publications including The New York Times, The Boston Globe and Slate. Aaron Schatz's FTN Football Almanac 2023 is still available for purchase, and is available in digital and paperback versions. About FTN Network FTN Network is a sports data B2B and fantasy sports and betting media B2C company. Founded in 2020, FTN gives the fantasy and sports betting community an edge through its own unique ecosystem, providing customizable tools that turn raw data into true insights while also offering expert analysis and content to help users make the best decision possible. FTN Network consists of FTN Fantasy (the home of fantasy football), FTN Daily (the home of daily fantasy sports), FTN Bets (the home of sports betting insights) and FTN Data (the home of NFL data). Contact Details Sterling A. Randle +1 801-319-6153 srandle@hotpaperlantern.com

August 29, 2023 10:01 AM Eastern Daylight Time

Article thumbnail News Release

FNIH and PathAI Forge Partnership to Advance Mucosal Healing in Ulcerative Colitis Research

PathAI

PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, is pleased to announce that the Foundation for the National Institute of Health's (FNIH) Biomarkers Consortium - Mucosal Healing in Ulcerative Colitis project team has selected PathAI to be its technology partner to further the study of mucosal healing, bring AI-assisted precision to disease assessment, and drive cutting-edge research to facilitate the development of new therapies for ulcerative colitis (UC), a disease affecting 1 to 2 million in the US alone. 1, 2 “Ulcerative colitis is an increasingly prevalent chronic disease. The lack of standardized measurement and definition of mucosal healing poses a significant challenge for UC drug development, limiting treatment options for patients,” said James O’Leary, Director, Inflammation and Immunity at the FNIH. Though nearly 200 active clinical trials support on-going development of new treatments and therapies, 3 no standard histological measure exists. “Through this collaborative project with PathAI, together we aim to establish a reproducible methodology for histological measurement of mucosal healing in UC treatment.” PathAI’s groundbreaking AI product, AIM-HI UC (AI-based Measurement of Histological Index for Ulcerative Colitis), will serve as the exclusive platform for automated Geboes-based disease assessment for the consortium. This innovative approach will provide invaluable insights into mucosal healing, enabling better capture of true drug effect/signal-to-noise ratio for UC treatments. Furthermore, this partnership holds the potential to fuel biomarker development by unraveling the inflammatory microenvironment of ulcerative colitis. The FNIH Biomarkers Consortium brings together eight prominent biopharmaceutical companies, two prominent disease area foundations, academic partners, and the FDA in an unprecedented effort to standardize and enhance disease assessment in the field of ulcerative colitis. By selecting PathAI as its technology partner, the consortium aims to leverage PathAI’s expertise in AI algorithms to achieve a more accurate and reproducible scoring of mucosal healing and provide improved prediction of long-term patient outcomes. The project will culminate in a common protocol and white paper that will be submitted to the FDA to influence regulatory guidance for future UC clinical trials. "PathAI's algorithms will elevate our ability to investigate novel relationships, signatures, and biomarkers in UC" said Andy Beck, CEO of PathAI. "By embracing an AI-driven standardized approach, we increase accuracy and reduce scoring variability for therapeutic response assessment. We are excited to be part of this groundbreaking project, with the ultimate goal of accurately predicting long-term patient outcomes and driving industry-wide consensus." One distinguishing feature of AIM-HI UC is that it is built on exhaustive WSI tissue segmentation and cell classification models, providing a quantitative and objective basis for a normally subjective assessment. Compared to traditional pathologist scoring, AIM-HI UC has demonstrated higher accuracy in measuring critical Geboes metrics essential to histological healing, including GS2A, GS2B, and GS3. AIM-HI UC is intended for research use only, not for use in diagnostic procedures, serving as a secondary and/or exploratory endpoint in clinical trials. It enables the identification of histologic remission (GS<2) and histologic improvement (GS≤3.1). Additionally, it facilitates translational research and retrospective deployment. To learn more about AIM-HI UC and the underlying algorithm driving this groundbreaking research, please visit www.pathai.com/aim-hiuc or contact PathAI. Footnotes 1 https://www.mayoclinic.org/diseases-conditions/ulcerative-colitis/multimedia/vid-20522485 2 https://www.asge.org/home/for-patients/patient-information/understanding-ulcerative-colitis 3 https://www.clinicaltrials.gov About PathAI PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of patient samples to improve efficiency and accuracy of pathology interpretation, as well as to better gauge therapeutic efficacy and accelerate drug development for complex diseases. PathAI, which is headquartered in Boston, MA, and operates a CAP/CLIA-certified laboratory in Memphis, TN, is proud to have a team of 600+ innovative thinkers from around the globe. For more information, please visit www.pathai.com. About FNIH The Foundation for the National Institute of Health (FNIH) is a non-profit organization that provides critical support to the National Institutes of Health (NIH). FNIH works to advance biomedical research by fostering public-private partnerships and collaborations that accelerate the development of new treatments and therapies. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

August 29, 2023 10:00 AM Eastern Daylight Time

Article thumbnail News Release

Velocity Global Expands Leadership to Drive Strategy Execution and Customer Success

Velocity Global

Velocity Global, the world’s expert on work, today announced the appointment of Susan McDonough as Chief Transformation Officer and Frank Lucier as Chief Customer Success Officer, effective August 28th and September 5th, respectively. In her role, Susan will manage and execute on Velocity Global’s long-term strategy and vision, driving key initiatives and leading a cross-functional team to make operational scale a reality. In his role, Frank will drive an even greater focus and emphasis on our customer journey. “As our industry matures and Velocity Global enters its next stage of growth, Susan and Frank will be a critical part of our leadership team. Their impressive and proven track record of transforming companies and creating meaningful customer journeys during crucial stages of development will allow us to achieve a sustainable and scalable growth strategy,” said Frank Calderoni, CEO at Velocity Global. Susan most recently led the Enterprise Transformation Office at global HR leader, Workday. Prior to that, she spent nearly two decades leading growth and driving scale at Cisco in roles spanning Customer Experience, Operations, Corporate Development and Finance. She is widely regarded as a transformation pioneer for her ability to translate strategy into operational execution. She joins Velocity Global at a pivotal point in the company’s trajectory as it scales across customer success, product innovation, and operational excellence. “I am passionate about creating high-performing teams that are driven to collaborate, innovate, and exceed customer expectations,” said Susan McDonough, Chief Transformation Officer at Velocity Global. “Joining a company that is laser-focused on making opportunity borderless for people everywhere caught my interest immediately and I am excited to execute on this important vision. I look forward to driving measurable growth and scale across all functions of the company, with the success of our customers in mind.” Frank has nearly 20 years of leadership experience in customer-centric technology and is an expert in prioritizing the customer journey that is holistic, impactful, and goes beyond metrics. He has previously held leadership roles at SAP Concur, ServiceSource, and iSpot.TV enhancing the customer experience and driving retention and business growth. “Velocity Global has built an impressive business helping companies scale and grow to reach new heights. Joining at this stage in their trajectory is an incredible opportunity and I look forward to ensuring every customer optimizes the value of working with us,” said Frank Lucier, Chief Customer Success Officer at Velocity Global. “My passion is to build teams that focus on helping customers achieve their business goals with measurable results. I’m excited to execute this strategy with the team to bring a world class experience to our customers." Susan and Frank’s announcements come shortly after the appointment of Ann-Christel Graham, who joined the company last month as its Chief Revenue Officer. Ann-Christel and Chief People Officer, Linda Lee, were both brought on by CEO Frank Calderoni, who took on the role in April. The company also recently launched a rebranding effort to more accurately represent its next phase of growth and scale. For more information on how Velocity Global makes opportunity borderless for people everywhere, visit www.velocityglobal.com. About Velocity Global Velocity Global gives you the power to build your team everywhere—combining seamless technology and local expertise in 185+ countries. We make it simple to compliantly hire, pay, and manage talent anywhere. With Velocity Global, the world is yours. Start hiring across borders at VelocityGlobal.com. Contact Details Media Contact press@velocityglobal.com Company Website https://velocityglobal.com/

August 29, 2023 08:00 AM Mountain Daylight Time

Image
1 ... 229230231232233 ... 645